Main content Erlotinib

    Erlotinib



    References

    Citations

    1. Burtness B, et al. (2009). NCCN Task Force Report: Management of dermatologic and other toxicities associated with EGFR inhibition in patients with cancer. Journal of the National Comprehensive Cancer Network, 7(Suppl 1): S5–S24.




    By: Reference Healthwise Staff Last Revised: September 12, 2012
    Medical Review: Reference E. Gregory Thompson, MD - Internal Medicine
    Reference Michael Seth Rabin, MD - Medical Oncology


    This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Reference Terms of Use. Reference How this information was developed to help you make better health decisions.


    Topic Contents